Otsuka Holdings Co., Ltd.: Stress Disorders, Post-Traumatic trials
The registry lists 11 Stress Disorders, Post-Traumatic studies with Otsuka Holdings Co., Ltd. as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 3Phase 2 4Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSDRecruitingNCT07836647Phase 3
- An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSDEnrolling by invitationNCT07670702Phase 3
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)RecruitingNCT07456696Phase 3
- A Study to Assess the Use of Methylone in the Treatment of PTSDCompletedNCT05741710Phase 1/2Results posted
- Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress DisorderCompletedNCT04174170Phase 3Results posted
- Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSDCompletedNCT04124614Phase 3Results posted
- A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)CompletedNCT03033069Phase 2Results posted
- A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy SubjectsCompletedNCT06303648Phase 1
- An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSDCompletedNCT06237426Phase 2
- An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDCompletedNCT06215261Phase 2
- A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/SertralineTerminatedNCT05189977Phase 1